CORC

浏览/检索结果: 共1条,第1-1条 帮助

限定条件        
已选(0)清除 条数/页:   排序方式:
Preliminary Results from a Phase I, First-in-Human Study of YY-20394, a Highly Selective and Highly Potent PI3K delta Inhibitor, in Patients with Relapsed or Refractory B-Cell Malignancies 会议论文
BLOOD, 2018-11-29
作者:  Qi, Junyuan;  Song, Yuqin;  Jiang, Bo;  Li, Jianyong;  Tu, Meifeng
收藏  |  浏览/下载:7/0  |  提交时间:2020/01/03


©版权所有 ©2017 CSpace - Powered by CSpace